Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $5.29B | $5.52B |
| COGS | — | — |
| Gross Profit | — | — |
| R&D | $0 | $0 |
| SG&A | $1.89B | $1.71B |
| D&A | $0 | $0 |
| Other OpEx | $2.39B | $2.11B |
QuarterCharts · SEC EDGAR data · FISV · Comparing FY2026 (Q2) vs FY2025 (Q2)
| Operating Income | $1.02B | $1.7B |
| Interest Exp. | $376M | $376M |
| Interest Income | $6M | — |
| Other Non-Op | $0 | $28M |
| Other Non-Op (derived) | $130M | — |
| Non-Op Income | $136M | $0 |
| Pretax Income | $775M | $1.29B |
| Tax | $156M | $246M |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Equity Method Income | $11M | — |
| Equity Method Income (Loss) | — | $16M |
| Tax Benefit | $0 | $0 |
| Net Income Consolidated | $630M | $1.03B |
| Noncontrolling Interest | $3M | $4M |
| Net Income | $627M | $1.03B |
